Literature DB >> 1618965

High-performance liquid chromatographic procedure for the determination of tiagabine concentrations in human plasma using electrochemical detection.

L E Gustavson1, S Y Chu.   

Abstract

A sensitive and precise high-performance liquid chromatographic procedure has been developed for the measurement of tiagabine concentrations in human plasma. Isolation of tiagabine and the internal standard was achieved using solid-phase extraction on disposable C8 columns. Separation was performed on a C18 analytical column using a mobile phase containing sodium octanesulfonate. The effluent was monitored with coulometric electrochemical detection at ca. + 0.76 V. The workup procedure recovered more than 95% of tiagabine from plasma. Standard curves were linear over the concentration range 0-500 ng/ml. The precision of the method was good: coefficients of variation were typically less than 5% for concentrations as low as 8 ng/ml and although they were higher at concentrations less than 8 ng/ml, they remained within acceptable limits (less than 17%) for concentrations as low as the limit of quantitation (2 ng/ml using a l-ml plasma sample). The stability of tiagabine in plasma was excellent, with no evidence of degradation after 23 h at room temperature or 2 months at -20 degrees C.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618965     DOI: 10.1016/0378-4347(92)80045-r

Source DB:  PubMed          Journal:  J Chromatogr


  6 in total

1.  Effect of amygdala kindling on the central nervous system effects of tiagabine: EEG effects versus brain GABA levels.

Authors:  A Cleton; B A Altorf; R A Voskuyl; M Danhof
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 2.  Is there a role for therapeutic drug monitoring of new anticonvulsants?

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

3.  Stereoselective central nervous system effects of the R- and S-isomers of the GABA uptake blocker N-(4, 4-di-(3-methylthien-2-yl)but-3-enyl) nipecotic acid in the rat.

Authors:  A Cleton; H J de Greef; P M Edelbroek; R A Voskuyl; M Danhof
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

4.  Modern methods for analysis of antiepileptic drugs in the biological fluids for pharmacokinetics, bioequivalence and therapeutic drug monitoring.

Authors:  Juseop Kang; Yoo-Sin Park; Shin-Hee Kim; Sang-Hyun Kim; Min-Young Jun
Journal:  Korean J Physiol Pharmacol       Date:  2011-04-30       Impact factor: 2.016

5.  Application of a combined "effect compartment/indirect response model" to the central nervous system effects of tiagabine in the rat.

Authors:  A Cleton; H J de Greef; P M Edelbroek; R A Voskuyl; M Danhof
Journal:  J Pharmacokinet Biopharm       Date:  1999-06

Review 6.  An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs.

Authors:  Shery Jacob; Anroop B Nair
Journal:  Drugs R D       Date:  2016-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.